Centene Corporation
General ticker "CNC" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $22.0B (TTM average)
Centene Corporation follows the US Stock Market performance with the rate: 51.7%.
Estimated limits based on current volatility of 1.7%: low 68.97$, high 71.33$
Factors to consider:
- Earnings expected soon, date: 2026-10-27 bmo
- Company included in S&P500 list
- Total employees count: 61100 (+1.0%) as of 2025
- Top business risk factors: Contract renewal failure, Third-party risks, Cybersecurity threats, Regulatory and compliance, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [43.25$, 74.78$]
- 2026-12-31 to 2027-12-31 estimated range: [51.84$, 85.97$]
Financial Metrics affecting the CNC estimates:
- Positive: with PPE of 19.7 at the end of fiscal year the price was neutral
- Positive: Operating cash flow per share per price, % of 25.62 > 24.19
- Positive: -13.52 < Operating profit margin, % of -3.77
- Negative: negative Net income
- Negative: 0 < Inventory ratio change, % of 0.03
- Positive: 0.90 < Industry operating cash flow per share per price (median), % of 3.62
- Negative: 2.54 < Interest expense per share per price, % of 3.41
Short-term CNC quotes
Relationship graph
Long-term CNC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $153,999.00MM | $163,071.00MM | $194,777.00MM |
| Operating Expenses | $151,069.00MM | $159,896.00MM | $202,400.00MM |
| Operating Income | $2,930.00MM | $3,175.00MM | $-7,623.00MM |
| Non-Operating Income | $668.00MM | $1,082.00MM | $895.00MM |
| Interest Expense | $725.00MM | $702.00MM | $678.00MM |
| Income(Loss) | $3,598.00MM | $4,257.00MM | $-6,728.00MM |
| Taxes | $899.00MM | $963.00MM | $-51.00MM |
| Net Income(Loss)* | $2,702.00MM | $3,305.00MM | $-6,674.00MM |
| Stockholders Equity | $25,840.00MM | $26,410.00MM | $19,953.00MM |
| Assets | $84,641.00MM | $82,445.00MM | $76,747.00MM |
| Operating Cash Flow | $8,053.00MM | $154.00MM | $5,088.00MM |
| Capital expenditure | $799.00MM | $644.00MM | $767.00MM |
| Investing Cash Flow | $-1,191.00MM | $-1,052.00MM | $472.00MM |
| Financing Cash Flow | $-1,658.00MM | $-2,406.00MM | $-1,621.00MM |
| Earnings Per Share** | $4.97 | $6.33 | $-13.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.